Michael Megaly to Humans
This is a "connection" page, showing publications Michael Megaly has written about Humans.
Connection Strength
3.294
-
Early vs. delayed mechanical circulatory support in patients with acute myocardial infarction and cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2024 May 28; 13(5):390-397.
Score: 0.052
-
Retrograde stent target technique for left main chronic total Occlusion revascularization. J Invasive Cardiol. 2023 Dec; 35(12).
Score: 0.050
-
Use of a Multidisciplinary Shock Team and Inhospital Mortality in Patients With Cardiogenic Shock. Am J Cardiol. 2023 11 01; 206:200-201.
Score: 0.049
-
The summer effect on STEMI outcomes: Insights from teaching hospitals. Cardiovasc Revasc Med. 2024 Jan; 58:101-103.
Score: 0.049
-
Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention of the Left Anterior Descending Artery. Am J Cardiol. 2023 04 15; 193:75-82.
Score: 0.048
-
Utilization of TandemHeart in cardiogenic shock: Insights from the THEME registry. Catheter Cardiovasc Interv. 2023 03; 101(4):756-763.
Score: 0.047
-
Meta-Analysis on Invasive Versus Conservative Strategy in Patients Older Than Seventy Years With Non-ST Elevation Myocardial Infarction. Am J Cardiol. 2023 01 01; 186:66-70.
Score: 0.047
-
Utilization of Non-Drug-Eluting Devices for Inpatient Percutaneous Coronary Intervention in the United States. Am J Cardiol. 2023 01 01; 186:209-215.
Score: 0.047
-
Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2022 11; 100(6):1021-1029.
Score: 0.046
-
Radial first for STEMI and cardiogenic shock: Jumping in the water with your wrists tied. Eur Heart J Qual Care Clin Outcomes. 2022 Sep 05; 8(6):600-601.
Score: 0.046
-
Comparative Analysis of Patient Characteristics in Chronic Total Occlusion Revascularization Studies: Trials vs Real-World Registries. JACC Cardiovasc Interv. 2022 07 25; 15(14):1441-1449.
Score: 0.046
-
Trends and Outcomes of Myocardial Infarction in Patients With Previous Coronary Artery Bypass Surgery. Am J Cardiol. 2022 09 15; 179:11-17.
Score: 0.046
-
The MANTA Vascular Closure Device: Requiring Attention From Beginning to End, Reply. Cardiovasc Revasc Med. 2022 07; 40:207.
Score: 0.045
-
Extra-Stent Subintimal Plaque Modification: A Novel Technique to Overcome Resistant Stent Underexpansion. Cardiovasc Revasc Med. 2022 07; 40S:276-278.
Score: 0.045
-
Comparative Analysis of Patient Characteristics in Cardiogenic Shock Studies: Differences Between Trials and Registries. JACC Cardiovasc Interv. 2022 02 14; 15(3):297-304.
Score: 0.044
-
Side Power Knuckle and Antegrade-Antegrade Dissection Re-Entry: Techniques to Overcome Difficulties in Chronic Occlusion?Revascularization. JACC Cardiovasc Interv. 2022 01 10; 15(1):e13-e15.
Score: 0.044
-
Wire Entrapment and Unraveling in the Aorta: Snaring Technique for the Nonvisible Filament. JACC Cardiovasc Interv. 2022 01 24; 15(2):e21-e22.
Score: 0.044
-
Incidence and Long-Term Outcomes of Stroke in Patients Presenting With ST-Segment Elevation-Myocardial Infarction: Insights From the Midwest STEMI Consortium. J Am Heart Assoc. 2021 12 07; 10(23):e022489.
Score: 0.044
-
"Power Carlino": A Novel Method for Modifying Wire-Impenetrable Proximal Caps During Chronic Total Occlusion Revascularization. JACC Cardiovasc Interv. 2021 11 22; 14(22):2521-2522.
Score: 0.043
-
Outcomes of successful vs. failed contemporary chronic total occlusion percutaneous coronary intervention. Cardiovasc Interv Ther. 2022 Jul; 37(3):483-489.
Score: 0.043
-
Complications and failure modes of coronary microcatheters. EuroIntervention. 2021 Aug 06; 17(5):e436-e438.
Score: 0.043
-
Diabetic Patients Who Present With ST-Elevation Myocardial Infarction. Cardiovasc Revasc Med. 2022 05; 38:89-93.
Score: 0.043
-
Trends and Outcomes of Uilization of Thrombectomy During Primary Percutaneous Coronary Intervention. Cardiovasc Revasc Med. 2022 03; 36:83-88.
Score: 0.042
-
Complications and Failure Modes of Polymer-Jacketed Guidewires; Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 03; 36:132-135.
Score: 0.042
-
Complications and failure modes of coronary embolic protection devices: Insights from the MAUDE database. Catheter Cardiovasc Interv. 2022 02; 99(2):405-410.
Score: 0.042
-
Complications and Failure Modes of Covered Coronary Stents: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 02; 35:157-160.
Score: 0.042
-
Outcomes With Drug-Coated Balloons vs. Drug-Eluting Stents in Small-Vessel Coronary Artery Disease. Cardiovasc Revasc Med. 2022 02; 35:76-82.
Score: 0.042
-
Complications and Failure Modes of Stingray LP Balloon: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 02; 35:187-188.
Score: 0.042
-
Complications of the MANTA Closure Device: Insights From MAUDE Database. Cardiovasc Revasc Med. 2022 01; 34:75-79.
Score: 0.041
-
Outcomes of Percutaneous and Surgical Pulmonary Valve Implantation. Cardiovasc Revasc Med. 2021 11; 32:27-32.
Score: 0.041
-
Reply: TAVR With or Without Embolic Cerebral Protection. JACC Cardiovasc Interv. 2020 12 14; 13(23):2817.
Score: 0.041
-
Impact of Chronic Total Occlusion Revascularization on Left Ventricular Function Assessed by Cardiac Magnetic Resonance. JACC Cardiovasc Imaging. 2021 05; 14(5):1076-1078.
Score: 0.041
-
Subintimal Plaque Modification and Subintimal Dissection and Reentry: Strategies to Turn Failure into Success. Interv Cardiol Clin. 2021 01; 10(1):65-73.
Score: 0.041
-
Systematic review and meta-analysis of short-term outcomes with drug-coated balloons vs. stenting in acute myocardial infarction. Cardiovasc Interv Ther. 2021 Oct; 36(4):481-489.
Score: 0.040
-
Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement. JACC Cardiovasc Interv. 2020 09 28; 13(18):2149-2155.
Score: 0.040
-
Use of Intravascular Imaging in Patients With ST-Segment Elevation Acute Myocardial Infarction. Cardiovasc Revasc Med. 2021 09; 30:59-64.
Score: 0.040
-
Risk Factors for the Development of Carotid Artery In-Stent Restenosis: Multivariable Analysis. Cardiovasc Revasc Med. 2021 03; 24:65-69.
Score: 0.040
-
Coronary Intravascular Brachytherapy for Recurrent Coronary Drug-Eluting Stent In-Stent Restenosis: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 02; 23:28-35.
Score: 0.040
-
Renin-angiotensin system antagonists are associated with lower mortality in hypertensive patients with COVID-19. Scott Med J. 2020 Nov; 65(4):123-126.
Score: 0.040
-
Outcomes With Combined Laser Atherectomy and Intravascular Brachytherapy in Recurrent Drug-Eluting Stent In-Stent Restenosis. Cardiovasc Revasc Med. 2021 01; 22:29-33.
Score: 0.039
-
Retrograde Approach to Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2020 05; 13(5):e008900.
Score: 0.039
-
Outcomes of Chronic Total?Occlusion Percutaneous Coronary Intervention in Patients With Prior Bypass Surgery. JACC Cardiovasc Interv. 2020 04 13; 13(7):900-902.
Score: 0.039
-
Short- and Long-Term Outcomes in Patients With New-Onset Persistent Left Bundle Branch Block After Transcatheter Aortic Valve Replacement. Cardiovasc Revasc Med. 2020 10; 21(10):1299-1304.
Score: 0.039
-
Primary Orbital Atherectomy for Treating a Heavily Calcified Balloon-Uncrossable Lesion. Cardiovasc Revasc Med. 2020 11; 21(11S):96-99.
Score: 0.038
-
Outcomes of intravascular brachytherapy for recurrent drug-eluting in-stent restenosis. Catheter Cardiovasc Interv. 2021 01 01; 97(1):32-38.
Score: 0.038
-
Outcomes after pacemaker implantation in patients with new-onset left bundle-branch block after transcatheter aortic valve replacement. Am Heart J. 2019 12; 218:128-132.
Score: 0.038
-
Outcomes with retrograde versus antegrade chronic total occlusion revascularization. Catheter Cardiovasc Interv. 2020 11; 96(5):1037-1043.
Score: 0.038
-
Outcomes With Deferred Versus Performed Revascularization of Coronary Lesions With Gray-Zone Fractional Flow Reserve Values. Circ Cardiovasc Interv. 2019 12; 12(12):e008315.
Score: 0.038
-
Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management. J Invasive Cardiol. 2019 Jul; 31(7):E177-E183.
Score: 0.037
-
Radial Versus Femoral Access in Chronic Total Occlusion Percutaneous Coronary Intervention. Circ Cardiovasc Interv. 2019 06; 12(6):e007778.
Score: 0.037
-
Outcomes with cilostazol after endovascular therapy of peripheral artery disease. Vasc Med. 2019 08; 24(4):313-323.
Score: 0.036
-
Outcomes with Drug-Coated Balloons in Percutaneous Coronary Intervention in Diabetic Patients. Cardiovasc Revasc Med. 2020 01; 21(1):78-85.
Score: 0.036
-
Outcomes with drug-coated balloons in small-vessel coronary artery disease. Catheter Cardiovasc Interv. 2019 04 01; 93(5):E277-E286.
Score: 0.035
-
Outcomes With Drug-Coated Balloons for Treating the Side Branch of Coronary Bifurcation Lesions. J Invasive Cardiol. 2018 11; 30(11):393-399.
Score: 0.035
-
Meta-analysis of the impact of successful chronic total occlusion percutaneous coronary intervention on left ventricular systolic function and reverse remodeling. J Interv Cardiol. 2018 Oct; 31(5):562-571.
Score: 0.034
-
Aminophylline for Preventing Bradyarrhythmias During Orbital or Rotational Atherectomy of the Right Coronary Artery. J Invasive Cardiol. 2018 May; 30(5):186-189.
Score: 0.034
-
Endovascular Repair of a Large Common Femoral Artery Pseudoaneurysm via a Retrograde Deep Femoral Arterial Access. Cardiovasc Intervent Radiol. 2016 Dec; 39(12):1792-1794.
Score: 0.030
-
Etravirine as a culprit of recurrent drug-eluting in-stent restenosis in an HIV patient. Int J Cardiol. 2016 Sep 15; 219:117-8.
Score: 0.030
-
Pyogenic granuloma-like Kaposi's sarcoma. Lancet. 2022 04 23; 399(10335):e38.
Score: 0.029
-
Outcomes of Intracoronary Brachytherapy for In-Stent Restenosis. Am J Cardiol. 2025 Jun 01; 244:89-98.
Score: 0.014
-
Impact of moderate or severe mitral and tricuspid valves regurgitation after transcatheter aortic valve replacement. Am Heart J. 2025 Feb; 280:79-88.
Score: 0.013
-
Clinical Outcomes of Patients Experiencing Transient Loss of Pulse Pressure During High-Risk PCI with Impella. J Card Fail. 2024 Oct; 30(10):1287-1299.
Score: 0.013
-
Impact of transcatheter edge to edge repair in functional mitral regurgitation and cardiac resynchronization-therapy nonresponders. Catheter Cardiovasc Interv. 2024 Oct; 104(4):829-836.
Score: 0.013
-
Radiation exposure during distal and traditional radial coronary angiography and percutaneous coronary intervention: a meta-analysis of randomized controlled trials. J Invasive Cardiol. 2023 Nov; 35(11).
Score: 0.012
-
Outcomes With Malignancy-Associated High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2024 Jan; 99(1):81-89.
Score: 0.012
-
Outcomes of Chronic Total Occlusion Percutaneous Coronary Interventions in Patients With Previous Coronary Artery Bypass Graft Surgery. Am J Cardiol. 2023 10 15; 205:40-49.
Score: 0.012
-
Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI. JACC Cardiovasc Interv. 2023 06 26; 16(12):1517-1528.
Score: 0.012
-
Extra-plaque rotational atherectomy for treating a balloon uncrossable ostial right coronary artery chronic total occlusion. Cardiovasc Revasc Med. 2024 Jan; 58:50-51.
Score: 0.012
-
The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study. Catheter Cardiovasc Interv. 2023 07; 102(1):159-165.
Score: 0.012
-
Outcomes with catheter-directed thrombolysis vs. catheter-directed embolectomy among patients with high-risk pulmonary embolism: a nationwide analysis. Eur Heart J Acute Cardiovasc Care. 2023 Apr 17; 12(4):224-231.
Score: 0.012
-
Intravascular Imaging Use in Percutaneous Coronary Interventions of Chronic Total Occlusions. J Invasive Cardiol. 2023 05; 35(5):E265-E268.
Score: 0.012
-
Meta-Analysis on Transcarotid Versus Transfemoral and Other Alternate Accesses for Transcatheter Aortic Valve Implantation. Am J Cardiol. 2023 04 01; 192:196-205.
Score: 0.012
-
Outcomes with plug-based versus suture-based vascular closure device after transfemoral transcatheter aortic valve replacement: A systematic review and meta-analysis. Catheter Cardiovasc Interv. 2023 03; 101(4):817-827.
Score: 0.012
-
Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry. Catheter Cardiovasc Interv. 2023 03; 101(4):737-746.
Score: 0.012
-
External validation of the PROGRESS-CTO complication risk scores: Individual patient data pooled analysis of 3 registries. Int J Cardiol. 2023 03 15; 375:14-20.
Score: 0.012
-
Use of Mechanical Circulatory Support in Chronic Total Occlusion Percutaneous Coronary Intervention. Am J Cardiol. 2023 02 15; 189:76-85.
Score: 0.012
-
Saphenous Vein Graft Occlusion Following Native Vessel Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 12; 34(12):E836-E840.
Score: 0.012
-
Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2022 11; 100(6):1010-1018.
Score: 0.012
-
A Systematic Review and Meta-Analysis of Clinical Outcomes of Patients Undergoing Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 11; 34(11):E763-E775.
Score: 0.012
-
Sex Differences in Management and Outcomes Among Patients With High-Risk Pulmonary Embolism: A Nationwide Analysis. Mayo Clin Proc. 2022 10; 97(10):1872-1882.
Score: 0.012
-
Hospital procedural volume and outcomes with catheter-directed intervention for pulmonary embolism: a nationwide analysis. Eur Heart J Acute Cardiovasc Care. 2022 Sep 29; 11(9):684-692.
Score: 0.012
-
Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry. Catheter Cardiovasc Interv. 2022 10; 100(4):512-519.
Score: 0.011
-
Contemporary National Trends and Outcomes of Pulmonary Embolism in the United States. Am J Cardiol. 2022 08 01; 176:132-138.
Score: 0.011
-
Digital health intervention in patients with recent hospitalization for acute heart failure: A systematic review and meta-analysis of randomized trials. Int J Cardiol. 2022 07 15; 359:46-53.
Score: 0.011
-
Transcatheter edge-to-edge repair of the tricuspid valve: The US?experience. Catheter Cardiovasc Interv. 2022 05; 99(6):1859-1866.
Score: 0.011
-
Temporal Trends in Retrograde Crossing of Epicardial Collaterals in Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2022 04; 34(4):E294-E295.
Score: 0.011
-
Estimate and Temporal Trends of Buerger Disease Hospitalizations in the United States. Am J Cardiol. 2022 04 15; 169:158-160.
Score: 0.011
-
In-hospital outcomes of transesophageal versus intracardiac echocardiography guided left atrial appendage closure. Catheter Cardiovasc Interv. 2022 04; 99(5):1572-1581.
Score: 0.011
-
Update on chronic total occlusion percutaneous coronary intervention. Prog Cardiovasc Dis. 2021 Nov-Dec; 69:27-34.
Score: 0.011
-
Complications of Penumbra Indigo Aspiration Device in Pulmonary Embolism: Insights From MAUDE Database. Cardiovasc Revasc Med. 2022 06; 39:97-100.
Score: 0.011
-
Sex Differences in Trends and In-Hospital Outcomes Among Patients With Critical Limb Ischemia: A Nationwide Analysis. J Am Heart Assoc. 2021 09 21; 10(18):e022043.
Score: 0.011
-
Impact of Hospital Procedural Volume on?Outcomes After Endovascular Revascularization for Critical Limb?Ischemia. JACC Cardiovasc Interv. 2021 09 13; 14(17):1926-1936.
Score: 0.011
-
Computed tomography angiography co-registration with real-time fluoroscopy in percutaneous coronary intervention for chronic total occlusions. EuroIntervention. 2021 Aug 06; 17(5):e433-e435.
Score: 0.011
-
Complications and Failure Modes of the Penumbra Indigo CAT RX Aspiration System in Percutaneous Coronary Intervention: Insights From the MAUDE Database. Cardiovasc Revasc Med. 2022 04; 37:147-148.
Score: 0.011
-
Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review. J Thromb Thrombolysis. 2022 Jan; 53(1):51-57.
Score: 0.011
-
Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
Score: 0.011
-
The transseptal puncture experience: Safety insights from FDA MAUDE database. Catheter Cardiovasc Interv. 2021 11 15; 98(6):E855-E861.
Score: 0.010
-
Meta-Analysis Comparing Direct Oral Anticoagulants to Vitamin K Antagonists for The Management of Left Ventricular Thrombus. Expert Rev Cardiovasc Ther. 2021 May; 19(5):427-432.
Score: 0.010
-
Coronary artery bypass grafting after acute ST-elevation myocardial infarction. J Thorac Cardiovasc Surg. 2023 02; 165(2):672-683.e10.
Score: 0.010
-
Benefit of Transcatheter Aortic Valve Replacement in Patients With Paradoxical Low-Flow Low-Gradient Versus High-Gradient Aortic Stenosis and Preserved Left Ventricular Function. Circ Cardiovasc Interv. 2021 03; 14(3):e010042.
Score: 0.010
-
Transcatheter Edge to Edge Repair With MitraClip Among Renal Transplant Recipients. Am J Cardiol. 2021 06 01; 148:178-180.
Score: 0.010
-
Contemporary Revascularization Strategies and Outcomes Among Patients With Diabetes With Critical Limb Ischemia: Insights From the National Inpatient Sample. JACC Cardiovasc Interv. 2021 03 22; 14(6):664-674.
Score: 0.010
-
DOACs for AF After?TAVR: Are DOACs Really on First Base? JACC Cardiovasc Interv. 2021 02 22; 14(4):481.
Score: 0.010
-
Hospital Volume and Outcomes of Coronary Atherectomy. Am J Cardiol. 2021 05 01; 146:140-141.
Score: 0.010
-
Outcomes of Transcarotid Versus Trans-Subclavian Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. Cardiovasc Revasc Med. 2021 12; 33:20-25.
Score: 0.010
-
Outcomes of transcatheter versus surgical aortic valve replacement among solid organ transplant recipients. Catheter Cardiovasc Interv. 2021 03; 97(4):691-698.
Score: 0.010
-
Impact of adherence to the hybrid algorithm for initial crossing strategy selection in chronic total occlusion percutaneous coronary intervention. Rev Esp Cardiol (Engl Ed). 2021 Dec; 74(12):1023-1031.
Score: 0.010
-
Transulnar Versus Transradial Access for Coronary Angiography and Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2021 05; 26:39-45.
Score: 0.010
-
Trends and Outcomes of Transcatheter Aortic Valve Implantation Among Solid Organ Transplant Recipients. Am J Cardiol. 2021 01 01; 138:122-124.
Score: 0.010
-
Temporal trends and outcomes of critical limb ischemia among patients with chronic kidney disease. Vasc Med. 2021 04; 26(2):155-163.
Score: 0.010
-
Outcomes with catheter-directed thrombolysis compared with anticoagulation alone in patients with acute deep venous thrombosis. Catheter Cardiovasc Interv. 2021 01 01; 97(1):E61-E70.
Score: 0.010
-
Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States. Catheter Cardiovasc Interv. 2021 08 01; 98(2):217-222.
Score: 0.010
-
Impact of Intravascular Ultrasound Utilization for Stent Optimization on 1-Year Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention. J Invasive Cardiol. 2020 Oct 01; 32(10):392-399.
Score: 0.010
-
Outcomes of Reoperative Coronary Artery Bypass Graft Surgery in the United States. J Am Heart Assoc. 2020 08 04; 9(15):e016282.
Score: 0.010
-
Impact of Successful Chronic Total Occlusion Percutaneous Coronary Interventions on Subsequent Clinical Outcomes. J Invasive Cardiol. 2020 Nov; 32(11):433-439.
Score: 0.010
-
Use of Direct Oral Anticoagulants in the Treatment of Left Ventricular Thrombi: A Systematic Review. Am J Med. 2020 11; 133(11):1266-1273.e6.
Score: 0.010
-
Clinical Characteristics and Outcomes?of?STEMI Patients With Cardiogenic Shock and Cardiac Arrest. JACC Cardiovasc Interv. 2020 05 25; 13(10):1211-1219.
Score: 0.010
-
Age-Stratified Sex Disparities in Care and Outcomes in Patients With ST-Elevation Myocardial Infarction. Am J Med. 2020 11; 133(11):1293-1301.e1.
Score: 0.010
-
The Impact of Novel X-Ray Systems and X-Ray System Optimization on Patient Radiation Dose Administered During Cardiac Catheterization. J Invasive Cardiol. 2020 06; 32(6):218-221.
Score: 0.010
-
Racial Disparities in the Utilization and Outcomes of Transcatheter Mitral Valve Repair: Insights From a National Database. Cardiovasc Revasc Med. 2020 11; 21(11):1425-1430.
Score: 0.010
-
Use of Radiation Protection Measures in Live Percutaneous Coronary Interventions Cases at Interventional Scientific Meetings. JACC Cardiovasc Interv. 2020 04 13; 13(7):905-906.
Score: 0.010
-
Distal Versus Conventional Transradial Artery Access for Coronary Angiography and Intervention: A Meta-Analysis. Cardiovasc Revasc Med. 2020 10; 21(10):1209-1213.
Score: 0.010
-
Retrograde Chronic Total Occlusion Percutaneous Coronary Intervention via?Saphenous Vein Graft. JACC Cardiovasc Interv. 2020 02 24; 13(4):517-526.
Score: 0.010
-
Sex Differences in In-Hospital Outcomes of Transcatheter Mitral Valve Repair (from a National Database). Am J Cardiol. 2020 05 01; 125(9):1391-1397.
Score: 0.010
-
Temporal Trends and Outcomes of Transcatheter Mitral Valve Repair Among Nonagenarians. JACC Cardiovasc Interv. 2020 06 08; 13(11):1385-1387.
Score: 0.010
-
Meta-Analysis Comparing Percutaneous to Surgical Access in Trans-Femoral Transcatheter Aortic Valve Implantation. Am J Cardiol. 2020 04 15; 125(8):1239-1248.
Score: 0.010
-
Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention. Catheter Cardiovasc Interv. 2020 11; 96(5):1029-1035.
Score: 0.010
-
Spontaneous coronary artery dissection: Primum non nocere. Hellenic J Cardiol. 2020 May - Jun; 61(3):229-230.
Score: 0.009
-
Meta-Analysis Comparing Torsemide Versus Furosemide in Patients With Heart Failure. Am J Cardiol. 2020 01 01; 125(1):92-99.
Score: 0.009
-
Temporal Trends and Outcomes of Mechanical Complications in Patients With Acute?Myocardial Infarction. JACC Cardiovasc Interv. 2019 09 23; 12(18):1825-1836.
Score: 0.009
-
In-Hospital Outcomes with Transfemoral Versus Transapical Access for Transcatheter Aortic Valve Replacement in Patients with Peripheral Arterial Disease. Cardiovasc Revasc Med. 2020 05; 21(5):604-609.
Score: 0.009
-
Impact of diastolic dysfunction on long-term mortality and quality of life after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 04 01; 95(5):1034-1041.
Score: 0.009
-
Low-Risk Transcatheter Versus Surgical Aortic Valve Replacement - An Updated Meta-Analysis of Randomized Controlled Trials. Cardiovasc Revasc Med. 2020 04; 21(4):441-452.
Score: 0.009
-
Aspirin for Primary Prevention of Cardiovascular?Events. J Am Coll Cardiol. 2019 06 18; 73(23):2915-2929.
Score: 0.009
-
Recent advances in microcatheter technology for the treatment of chronic total occlusions. Expert Rev Med Devices. 2019 Apr; 16(4):267-273.
Score: 0.009
-
In-hospital outcomes of transcatheter versus surgical aortic valve replacement for nonagenarians. Catheter Cardiovasc Interv. 2019 04 01; 93(5):989-995.
Score: 0.009
-
Outcomes of Surgical Ablation in Patients With Atrial Fibrillation Undergoing Cardiac Surgeries. Ann Thorac Surg. 2019 May; 107(5):1395-1400.
Score: 0.009
-
Flow convergence visualized in mitral regurgitation with spontaneous echo contrast. Int J Cardiovasc Imaging. 2019 Mar; 35(3):439-440.
Score: 0.009
-
Reply. Ann Thorac Surg. 2018 11; 106(5):1590-1591.
Score: 0.009
-
Meta-Analysis of Trials on Prophylactic Use of Levosimendan in Patients Undergoing Cardiac Surgery. Ann Thorac Surg. 2018 05; 105(5):1403-1410.
Score: 0.008
-
Meta-Analysis of Randomized Trials of Intracoronary Versus Intravenous Glycoprotein IIb/IIIa Inhibitors in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention. Am J Cardiol. 2017 Oct 01; 120(7):1055-1061.
Score: 0.008